Physician profile
David C White
NPI 1487673869
$16,361.90
in general payments reported to CMS, 2019-2025
12 companies · $92.18 in 2025
The $92.18 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,724 · 2021: $97.43 · 2023: $8,382 · 2024: $5,067 · 2025: $92.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,367 · Travel and Lodging: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $1,366.75 |
| Travel and Lodging | $174.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,563.11 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $164.95 | 2024 | Progel Applicator Spray Tips, Arista Ah Flexitip |
| Conmed Corporation | $132.27 | 2024 | Airseal |
| Merck Sharp & Dohme LLC | $100.56 | 2024-2025 | Keytruda, Zerbaxa |
| Ethicon INC. | $97.43 | 2021 | |
| Pinnacle Biologics, INC | $84.19 | 2019 | |
| Medtronic, INC. | $82.07 | 2023 | |
| Integra Lifesciences Corporation | $48.45 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Heron Therapeutics, INC. | $36.70 | 2025 | Zynrelef |
| Atricure, INC. | $20.12 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Olympus America INC. | $18.49 | 2025 | 4k Camera Head, Visera 4k Uhd Camera Control Unit |
| Kls-Martin L.P. | $13.56 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.